Browsing by Subject "Osteoblast"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.(2010-03) Hoeppner, Luke HilbertThe canonical Wnt signaling pathway has emerged as an important regulator of bone formation, regeneration and repair. Studies over the past decade have demonstrated that activation of canonical Wnt signaling generally promotes osteoblast proliferation and enhances bone mass, while suppression of Wnt signaling results in bone loss. Gaining a better understanding of Wnt signaling in the context of skeletal metabolism is important because current skeletal regeneration and repair treatments have limitations, anti-resorptive therapies have unknown long-term health consequences and the demand for therapies is rising as our population ages. Osteoporosis is a growing healthcare challenge that affects about 44 million Americans. Cancer survival rates drop drastically in patients suffering from bone metastases. A complete, molecular understanding of the canonical Wnt signaling cascade in the context of skeletal biology will promote the development of new therapies for the treatment of osteoporosis, skeletal cancer metastasis, and other skeletal diseases that result in uncoupling of bone formation and resorption. Lymphoid Enhancer Binding Factor (Lef) 1 is a transcription factor in the canonical Wnt/The canonical Wnt signaling pathway has emerged as an important regulator of bone formation, regeneration and repair. Studies over the past decade have demonstrated that activation of canonical Wnt signaling generally promotes osteoblast proliferation and enhances bone mass, while suppression of Wnt signaling results in bone loss. Gaining a better understanding of Wnt signaling in the context of skeletal metabolism is important because current skeletal regeneration and repair treatments have limitations, anti-resorptive therapies have unknown long-term health consequences and the demand for therapies is rising as our population ages. Osteoporosis is a growing healthcare challenge that affects about 44 million Americans. Cancer survival rates drop drastically in patients suffering from bone metastases. A complete, molecular understanding of the canonical Wnt signaling cascade in the context of skeletal biology will promote the development of new therapies for the treatment of osteoporosis, skeletal cancer metastasis, and other skeletal diseases that result in uncoupling of bone formation and resorption. Lymphoid Enhancer Binding Factor (Lef) 1 is a transcription factor in the canonical Wnt/Lrp5/6/β-catenin signaling cascade, which regulates osteoblast differentiation, bone density and skeletal strength. In this thesis, I describe the expression and function of an alternative Lef1 isoform in osseous cells. Lef1ΔN is a naturally occurring isoform driven by a promoter (p2) within the intron between exons 3 and 4 of Lef1. Lef1ΔN is induced during late osteoblast differentiation. This is opposite to the expression pattern of the full-length Lef1 protein, which as we previously showed, decreases during differentiation. We showed that the Lef1ΔN p2 promoter is active in osteoblasts and Runx2 positively regulates its activity. BMP2 also promotes Lef1ΔN expression, whereas Wnt3a represses it. Lef1ΔN overexpression in differentiating osteoblasts induced osteocalcin and type 1 collagen expression, which suggests Lef1ΔN is a crucial regulator of terminal differentiation in osseous cells. We found Lef1ΔN interacts with β-catenin to activate a Lef1-responsive promoter and stimulate the transcription of genes involved in late osteoblast differentiation. We mapped the region of Lef1ΔN that associates with β-catenin to an element within the first 61 amino acids of Lef1ΔN and showed this region was required to induce type 1 collagen and osteocalcin expression during osteoblast maturation. Taken together, Lef1ΔN interacts with β-catenin to regulate terminal differentiation in osseous cells.Item Role of twisted gastrulation and matrix gamma-carboxyglutamic acid protein in bone homeostasis.(2012-05) Sotillo Rodriguez, Julio EliezerThe regulation signaling activity of osteoblasts and osteoclasts has been linked to extracellular proteins, including twisted gastrulation (TWSG1) and matrix gamma-carboxyglutamic acid protein (MGP). TWSG1 is a regulator of bone morphogenetic proteins (BMPs) signaling activity. Previous studies have shown that TWSG1 is an essential modulator of not only skeletal development but also soft tissue development (i.e. salivary gland). MGP is a vitamin K-dependent protein previously characterized as a potent inhibitor of biomineralization. Numerous cells types produce MGP, including osteoblasts, chondrocytes, vascular smooth muscle cells and endothelial cells. Despite current research, little is known about the effects of TWSG1 and MGP on the regulation of osteoblasts and osteoclasts. Both of which are cells that maintain bone remodeling. In this dissertation, we assessed the role of both TWSG1 and MGP in postnatal bone homeostasis as well as in vitro functional analysis of TWSG1 and MGP on osteoblasts and osteoclasts. We were able to determine that the C57BL/6 MGP deficient mice and 129Sv/Ev TWSG1 deficient mice exhibited an osteopenic skeletal phenotype. This phenotype was explained by an imbalance in the cellular regulatory patterns associated with the regulation of homeostatic bone remodeling. Further, we characterized cellular pathways which explained how, in both TWSG1 and MGP deficient mice, excessive osteoclastic activity was the name culprit in the osteopenic phenotypes. Taken together, our results highlight the importance in the modulation of osteoblastic and osteoclastic activity by TWSG1 and MGP.